A total of 577 patients were randomly assigned (1:1:1) to receive once-weekly dulaglutide (1.5 mg), once-weekly dulaglutide (0.75 mg), or daily insulin glargine as basal therapy, all in combination with insulin lispro, for 52 weeks
Transition to a maintenance dose: Gradually reducing to a lower maintenance dose may help sustain your weight without the full dose
In the TRIUMPH-1 trial, the 4 mg dose had a lower discontinuation rate due to adverse events than even placebo, suggesting that lower doses are well-tolerated
As mentioned earlier, patients with certain thyroid cancer histories should not use some GLP-1 medications
But skipping it is one of the fastest ways to contaminate a vial that needs to last 28 days
Set phone alarms for your chosen injection day in your destination time zone